We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App





Siemens Presents Latest Innovations and Trends in Clinical Diagnostics and POC Testing

By LabMedica International staff writers
Posted on 21 May 2023

Siemens Healthineers (Erlangen, Germany) is presenting its newest innovations at WorldLab–EuroMedLab Roma 2023 that aim to help deliver high-value care, and confidently provide the answers expected by clinicians and patients. More...

A team of company experts is demonstrating innovations and trends in clinical diagnostics and point-of-care testing at the industry event.

On display at the Siemens booth are the company’s two new solutions for high-volume hematology testing, the Atellica HEMA 570 Analyzer and the Atellica HEMA 580 Analyzer. Both hematology analyzers offer integrated automation and intelligence to eliminate barriers that hamper workflow efficiency and deliver faster patient results. The Atellica HEMA 570 and Atellica HEMA 580 Analyzers have a throughput of up to 120 tests per hour and feature user-friendly designs that significantly reduce time-consuming daily maintenance and support rapid reagent changes.

The Atellica HEMA 570 and Atellica HEMA 580 Analyzers adopt advanced data management capabilities to eliminate the expertise gap and empower staff of all skill levels during result interpretations. In order to save time and provide physicians with information more quickly, normal results that do not violate pre-established criteria are released directly into a laboratory information system using the analyzers' rules-based auto-validation capability. Abnormalities are flagged and coded on the basis of severity to provide a clear indication of which patient samples need closer attention from the technician. In case results require follow-up actions like dilutions or slide reviews, standardized guidance is displayed to ensure that staff performs the next steps in accordance with lab protocols.

"We hear from labs that they need agility, reliability, and speed," said Sharon Bracken, Head of Diagnostics, Siemens Healthineers. "The Atellica HEMA analyzers combine workflow improvements with demonstrated technology to bring hematology testing into the future. We're delivering the breakthroughs labs need to produce quality patient results faster."

Related Links:
Siemens Healthineers 


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.